ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP)

105 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value as of Q2 2025.
ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 33,625,800 shares of 40,225,592 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4,484,672 shares), INFINITUM ASSET MANAGEMENT, LLC (3,418,923 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3,412,788 shares), ORBIMED ADVISORS LLC (3,027,328 shares), FMR LLC (2,058,069 shares), Octagon Capital Advisors LP (1,946,054 shares), NOVO HOLDINGS A/S (1,872,142 shares), BlackRock, Inc. (1,838,376 shares), Sofinnova Investments, Inc. (1,696,752 shares), and General Catalyst Group Management, LLC (1,494,786 shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.